Acute desflurane or sevoflurane exposure on a previously stabilized atracurium-induced neuromuscular block

European Journal of Anaesthesiology

Volumn 23, Issue 9, 2006, Pages 755-759

  Beaussier, M ^a   Boughaba, A ^a   Schiffer, E ^b   Debaene, B ^c   Lienhart, A ^a   D'Hollander, A ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anaesthetics inhalation, desflurane, sevoflurane; Drug interaction; Monitoring intraoperative, neuromuscular function; Neuromuscular non depolarizing agents, atracurium

Indexed keywords

ATRACURIUM; DESFLURANE; PROPOFOL; SEVOFLURANE; SUFENTANIL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; MUSCLE CONTRACTILITY; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING;

ADULT; ANESTHETICS, INHALATION; ATRACURIUM; CALIBRATION; FEMALE; HUMANS; ISOFLURANE; MALE; METHYL ETHERS; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES;

EID: 33746889064     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506000706     Document Type: Article

References (14)

1. Eger II E, Eisenkraft J, Weiskopf R. Neuromuscular effects of inhaled anesthetics. In: Eger II E, ed. The Pharmacology of Inhaled Anesthetics. Sponsored by the Danmiller Memorial Educational Foundation, Educational Grant from Baxter Healthcare Corporation, 2003: 133-145.
2. Baurain M, d'Hollander A, Melot C, Dernovoi B, Barvais L. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 1991; 74: 474-478.
3. Cannon J, Fahey M, Castagnoli K et al. Continuous infusion of vecuronium: the effect of anesthetic agents. Anesthesiology 1987; 67: 503-506.
4. Meretoja O, Wirtavuori K, Taivainen T, Olkkola K. Time course of potentiation of mivacurium by halothane and isoflurane in children. Br J Anaesth 1996; 76: 235-238.
5. Yasuda N, Targ A, Eger II E. Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989; 69: 370-373.
6. Viby-Mogensen J, Engbaek J, Eriksson L et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74.
7. Vanlinthout L, Booij L, van Egmond J, Robertson E. Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium. Br J Anaesth 1996; 76: 389-395.
8. Wulf H, Kahl M, Ledowski T. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia. Br J Anaesth 1998; 80: 308-312.
9. Hemmerling T, Schuettler J, Schwilden H. Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol. Can J Anesth 2001; 48: 532-537.
10. Wright P, Hart P, Lau M et al. The magnitude and time course of vecuronium potentiation by desflurane versus isoflurane. Anesthesiology 1995; 82: 404-411.
11. Yasuda N, Lockhart S, Eger II E et al. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 1991; 74: 489-498.
12. Violet J, Downie D, Nakisa R, Lieb W, Franks N. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology 1997; 86: 866-874.
13. Paul M, Fokt R, Kindler C, Dipp N, Yost C. Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor. Anesth Analg 2002; 95: 362-367.
14. Parker C, Hunter J, Snowdon S. Effect of age, sex and anaesthetic technique on pharmacokinetics of atracurium. Br J Anaesth 1992; 69: 439-443.